Autophagy‑dependent lysosomal amino acid efflux gates p16INK4a‑driven senescence in renal tubular epithelium

The siege metaphor for autophagy predicts that when nutrients are scarce the cell sacrifices non‑essential components to sustain core functions. In aging kidney, chronic nutrient stress may lock autophagy into a rationing mode that continuously feeds lysosomal catabolism, altering the intracellular amino acid pool that signals to mTORC1 and downstream transcription factors governing p16INK4a expression. We hypothesize that lysosomal efflux of essential amino acids—not autophagic degradation per se—determines whether p16INK4a is induced, such that enhancing efflux can bypass the senescence checkpoint even when autophagic flux is impaired.

Mechanistic rationale

1. Autophagy delivers cytosolic cargo to lysosomes where proteases generate free amino acids.
2. Lysosomal efflux transporters (e.g., SLC38A9, SLC7A5) export these amino acids to the cytosol, reactivating mTORC1 on the lysosomal surface.
3. Active mTORC1 suppresses TF‑EB nuclear translocation and reduces FoxO‑mediated transcription of p21 and p16INK4a.
4. When efflux is blocked, lysosomal amino acid accumulation creates a feedback inhibition of mTORC1 (via Ragulator‑Rag GTPases), sustaining FoxO nuclear activity and driving p16INK4a transcription independent of autophagic flux.

This model reframes autophagy inhibition not as a simple loss of clearance but as a shift in lysosomal nutrient signaling that pushes the cell toward senescence commitment.

Testable predictions

• In murine renal tubular epithelial cells, pharmacological blockade of lysosomal amino acid efflux (using leucine‑analog inhibitor of SLC7A5 or siRNA against SLC38A9) will increase p16INK4a‑positive cells and SA‑β‑Gal activity even when autophagic flux is enhanced by rapamycin or Torin1.
• Conversely, overexpression of SLC7A5 or pharmacological activation of lysosomal efflux (e.g., with L‑leucine supplementation) will reduce p16INK4a induction in cells treated with autophagy inhibitors (chloroquine, bafilomycin A1) or subjected to chronic TGF‑β stimulation.
• The effect will be specific to the tubular epithelium; podocytes, which rely more on TFEB‑driven lysosomal biogenesis, will show a weaker correlation between efflux manipulation and p16INK4a levels.

Experimental outline

1. Isolate primary mouse renal tubular epithelial cells and transduce with lentiviral sensors for mTORC1 activity (Raptor‑GFP lysosomal localization) and FoxO nuclear translocation (FoxO3‑mCherry).
2. Treat cells with: (a) vehicle, (b) autophagy inducer (rapamycin), (c) autophagy inhibitor (chloroquine), each combined with either SLC7A5 siRNA or leucine supplementation.
3. Measure after 48 h: (i) autophagic flux (LC3‑II turnover), (ii) lysosomal amino acid levels (LC‑MS/MS), (iii) mTORC1 activity (p‑S6K), (iv) FoxO localization, (v) p16INK4a mRNA/protein and SA‑β‑Gal positivity.
4. In parallel, perform kidney‑specific Slc7a5 knockout mice subjected to unilateral ureteral obstruction (UUO) to assess in vivo senescence markers (p16INK4a, SASP cytokines) and fibrosis.

Falsifiability If lysosomal amino acid efflux does not modulate p16INK4a expression—i.e., efflux blockade fails to increase senescence despite altered lysosomal amino acid pools, or efflux activation does not rescue senescence under autophagy inhibition—then the hypothesis is refuted. This would support the alternative view that autophagy’s proteolytic output, rather than its nutrient signaling, drives the senescence checkpoint.

By linking lysosomal nutrient export to the p16INK4a senescence axis, this hypothesis converts autophagy from a passive cleanup crew into an active rheostat that decides whether the cell endures the siege or commits to irreversible growth arrest.